275 related articles for article (PubMed ID: 24835407)
1. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Kawamoto Y; Ito H; Ayaki T; Takahashi R
Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
[TBL] [Abstract][Full Text] [Related]
2. Activated caspase-9 immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.
Kawamoto Y; Ayaki T; Urushitani M; Ito H; Takahashi R
Neurosci Lett; 2016 Aug; 628():207-12. PubMed ID: 27345387
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
Kawamoto Y; Ito H; Ihara M; Takahashi R
Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-17-mediated down-regulation of apoptotic protease activating factor 1 attenuates apoptosome formation and subsequent apoptosis of cardiomyocytes.
Song S; Seo HH; Lee SY; Lee CY; Lee J; Yoo KJ; Yoon C; Choi E; Hwang KC; Lee S
Biochem Biophys Res Commun; 2015 Sep; 465(2):299-304. PubMed ID: 26265044
[TBL] [Abstract][Full Text] [Related]
5. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
6. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
7. A molecular view on signal transduction by the apoptosome.
Reubold TF; Eschenburg S
Cell Signal; 2012 Jul; 24(7):1420-5. PubMed ID: 22446004
[TBL] [Abstract][Full Text] [Related]
8. Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.
Kokoulina P; Rohn TT
Neurodegener Dis; 2010; 7(4):243-50. PubMed ID: 20551689
[TBL] [Abstract][Full Text] [Related]
9. Cell death mechanisms in Parkinson's disease.
Jellinger KA
J Neural Transm (Vienna); 2000; 107(1):1-29. PubMed ID: 10809400
[TBL] [Abstract][Full Text] [Related]
10. Optimal pathways for the assembly of the Apaf-1·cytochrome c complex into apoptosome.
Qi H; Jiang Y; Yin Z; Jiang K; Li L; Shuai J
Phys Chem Chem Phys; 2018 Jan; 20(3):1964-1973. PubMed ID: 29299551
[TBL] [Abstract][Full Text] [Related]
11. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
12. Apaf-1: Regulation and function in cell death.
Shakeri R; Kheirollahi A; Davoodi J
Biochimie; 2017 Apr; 135():111-125. PubMed ID: 28192157
[TBL] [Abstract][Full Text] [Related]
13. Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release.
Karki P; Seong C; Kim JE; Hur K; Shin SY; Lee JS; Cho B; Park IS
Cell Death Differ; 2007 Dec; 14(12):2068-75. PubMed ID: 17885667
[TBL] [Abstract][Full Text] [Related]
14. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W
Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039
[TBL] [Abstract][Full Text] [Related]
15. Loss of WD2 subdomain of Apaf-1 forms an apoptosome structure which blocks activation of caspase-3 and caspase-9.
Noori AR; Tashakor A; Nikkhah M; Eriksson LA; Hosseinkhani S; Fearnhead HO
Biochimie; 2021 Jan; 180():23-29. PubMed ID: 33132160
[TBL] [Abstract][Full Text] [Related]
16. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
17. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
[TBL] [Abstract][Full Text] [Related]
18. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies.
Higashi S; Moore DJ; Minegishi M; Kasanuki K; Fujishiro H; Kabuta T; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H; Wada K; Iseki E
J Neuropathol Exp Neurol; 2011 Apr; 70(4):264-80. PubMed ID: 21412173
[TBL] [Abstract][Full Text] [Related]
19. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.
Seidel K; Mahlke J; Siswanto S; Krüger R; Heinsen H; Auburger G; Bouzrou M; Grinberg LT; Wicht H; Korf HW; den Dunnen W; Rüb U
Brain Pathol; 2015 Mar; 25(2):121-35. PubMed ID: 24995389
[TBL] [Abstract][Full Text] [Related]
20. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
